Neuropace Stock Price on December 20, 2024
| NPCE Stock | USD 11.53 0.39 3.50% |
If you're considering investing in Neuropace Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neuropace stands at 11.53, as last reported on the 23rd of December, with the highest price reaching 11.59 and the lowest price hitting 10.76 during the day. Neuropace appears to be slightly risky, given 3 months investment horizon. Neuropace has Sharpe Ratio of 0.16, which conveys that the firm had a 0.16% return per unit of risk over the last 3 months. By analyzing Neuropace's technical indicators, you can evaluate if the expected return of 0.87% is justified by implied risk. Please exercise Neuropace's Risk Adjusted Performance of 0.1274, downside deviation of 3.72, and Mean Deviation of 3.67 to check out if our risk estimates are consistent with your expectations.
At present, Neuropace's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. . At present, Neuropace's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 13.55, whereas Price Earnings Ratio is forecasted to decline to (8.49). Neuropace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Neuropace |
Sharpe Ratio = 0.1614
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NPCE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.41 actual daily | 48 52% of assets are more volatile |
Expected Return
| 0.87 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Neuropace is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neuropace by adding it to a well-diversified portfolio.
Price Book 35.035 | Enterprise Value Ebitda (16.94) | Price Sales 4.5015 | Shares Float 11.2 M | Wall Street Target Price 16.1667 |
Related Headline
Cigna Corp Headline on 20th of December 2024
Filed transaction by Cigna Corp Officer Chief Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Neuropace Valuation on December 20, 2024
It is possible to determine the worth of Neuropace on a given historical date. On December 20, 2024 Neuropace was worth 11.0 at the beginning of the trading date compared to the closed value of 11.53. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neuropace stock. Still, in general, we apply an absolute valuation method to find Neuropace's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neuropace where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neuropace's related companies.
| Open | High | Low | Close | Volume | |
| 11.01 | 11.66 | 10.76 | 11.14 | 55,515 | |
12/20/2024 | 11.00 | 11.59 | 10.76 | 11.53 | 188,294 |
| 11.00 | 11.59 | 10.76 | 11.53 | 0.00 |
| Backtest Neuropace | | | Neuropace History | | | Neuropace Valuation | Previous | Next |
Neuropace Trading Date Momentum on December 20, 2024
| On December 23 2024 Neuropace was traded for 11.53 at the closing time. The top price for the day was 11.59 and the lowest listed price was 10.76 . There was no trading activity during the period 0.0. Lack of trading volume on December 23, 2024 did not cause price change. The trading delta at closing time against the current closing price is 4.60% . |
Neuropace Fundamentals Correlations and Trends
By evaluating Neuropace's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neuropace's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neuropace financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Neuropace Stock history
Neuropace investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neuropace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neuropace will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neuropace stock prices may prove useful in developing a viable investing in Neuropace
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 25.9 M | 27 M | |
| Net Loss | -42.4 M | -44.5 M |
Neuropace Quarterly Net Working Capital |
|
Neuropace Stock Technical Analysis
Neuropace technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Neuropace Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Neuropace cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Neuropace December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Neuropace stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuropace shares will generate the highest return on investment. By undertsting and applying Neuropace stock market strength indicators, traders can identify Neuropace entry and exit signals to maximize returns
Neuropace Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neuropace's price direction in advance. Along with the technical and fundamental analysis of Neuropace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neuropace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1274 | |||
| Jensen Alpha | 0.7814 | |||
| Total Risk Alpha | 0.6419 | |||
| Sortino Ratio | 0.2088 | |||
| Treynor Ratio | 1.02 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Neuropace Stock analysis
When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |